NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Baudax Bio Inc (NASDAQ: BXRX)
BXRX Technical Analysis
5
As on 9th Jun 2023 BXRX STOCK Price closed @ 0.55 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.84 & Strong Sell for SHORT-TERM with Stoploss of 0.88 we also expect STOCK to react on Following IMPORTANT LEVELS. |
BXRXSTOCK Price
Open | 0.55 | Change | Price | % |
High | 0.57 | 1 Day | -0.03 | -5.17 |
Low | 0.52 | 1 Week | 0.03 | 5.77 |
Close | 0.55 | 1 Month | -1.22 | -68.93 |
Volume | 247700 | 1 Year | 0.20 | 57.14 |
52 Week High 5.20 | 52 Week Low 0.12 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
BXRX Daily Charts |
BXRX Intraday Charts |
Whats New @ Bazaartrend |
BXRX Free Analysis |
|
BXRX Important Levels Intraday
RESISTANCE | 0.65 |
RESISTANCE | 0.62 |
RESISTANCE | 0.60 |
RESISTANCE | 0.58 |
SUPPORT | 0.52 |
SUPPORT | 0.50 |
SUPPORT | 0.48 |
SUPPORT | 0.45 |
BXRX Forecast May 2024
4th UP Forecast | 0.8 |
3rd UP Forecast | 0.72 |
2nd UP Forecast | 0.67 |
1st UP Forecast | 0.62 |
1st DOWN Forecast | 0.48 |
2nd DOWN Forecast | 0.43 |
3rd DOWN Forecast | 0.38 |
4th DOWN Forecast | 0.3 |
BXRX Weekly Forecast
4th UP Forecast | 0.84 |
3rd UP Forecast | 0.75 |
2nd UP Forecast | 0.69 |
1st UP Forecast | 0.63 |
1st DOWN Forecast | 0.47 |
2nd DOWN Forecast | 0.41 |
3rd DOWN Forecast | 0.35 |
4th DOWN Forecast | 0.26 |
BXRX Forecast2024
4th UP Forecast | 13.6 |
3rd UP Forecast | 9.41 |
2nd UP Forecast | 6.83 |
1st UP Forecast | 4.24 |
1st DOWN Forecast | -3.14 |
2nd DOWN Forecast | -5.73 |
3rd DOWN Forecast | -8.31 |
4th DOWN Forecast | -12.5 |
Baudax Bio Inc ( NASDAQ USA Symbol : BXRX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
BXRX Other Details
Segment | EQ | |
Market Capital | 47755384.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
BXRX Address
BXRX Latest News
BXRX Business Profile
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuromuscular blocking agent (NMBA) that is in phase I clinical trial; BX2000, an ultrashort-acting NMBA, which is in pre-clinical trial; and BX3000, an NMBA reversal agent, which is under pre-clinical trial, as well as Dex-IN, a proprietary intranasal formulation of dexmedetomidine, which is under phase II clinical trial. The company was incorporated in 2019 and is based in Malvern, Pennsylvania. Address: 490 Lapp Road, Malvern, PA, United States, 19355
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service